GMP LICENSED MICROBIOME THERAPEUTICS CDMO

Our in-house scientific expertise enables us to approach every project from the most fundamental principles. Delivering success to our customers during formulation development, process engineering, manufacturing, regulatory and clinical evaluation.

We create robust formulation development strategies tailored to the characteristics of each individual API with a proven track record of developing formulations containing anaerobes, bacteriophages, GMO strains, and human-derived consortia into safe, effective dosage forms. 

SGS Quay Pharma’s expertise and GMP-accredited state-of-the-art manufacturing facilities mean that it is uniquely placed to offer fast access to clinical manufacturing and packaging for phase I, II & III clinical trials coupled with global clinical distribution logistics.